Daiana Ibarretxe
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 30
-
- Lipid metabolism and disorders 21
- Surgery top 10%
- Lipoproteins and Cardiovascular Health 43
-
- Cancer, Lipids, and Metabolism 9
-
- Diet and metabolism studies 6
-
- Metabolomics and Mass Spectrometry Studies 7
-
- Health Systems, Economic Evaluations, Quality of Life 7
-
- Liver Disease Diagnosis and Treatment 7
Daiana Ibarretxe
78 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Endocrinology, Diabetes and Metabolism 314
- Cardiology and Cardiovascular Medicine 288
- Surgery 475
- Cancer Research 142
- Physiology 130
Countries citing papers authored by Daiana Ibarretxe
This map shows the geographic impact of Daiana Ibarretxe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daiana Ibarretxe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daiana Ibarretxe more than expected).
Fields of papers citing papers by Daiana Ibarretxe
This network shows the impact of papers produced by Daiana Ibarretxe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daiana Ibarretxe. The network helps show where Daiana Ibarretxe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daiana Ibarretxe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutationbreakdown → | 2025 | 16 |
| 2 | 2025 | 12 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 4 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 1 | |
| 13 | 2021 | 9 | |
| 14 | 2021 | 1 | |
| 15 | 2020 | 7 | |
| 16 | 2020 | 34 | |
| 17 | 2018 | 2 | |
| 18 | 2018 | 8 | |
| 19 | 2014 | 19 | |
| 20 | 2014 | 3 |
About Daiana Ibarretxe
Daiana Ibarretxe is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery, having authored 83 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (43 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (30 papers), Lipid metabolism and disorders (21 papers), Cancer, Lipids, and Metabolism (9 papers), Metabolomics and Mass Spectrometry Studies (7 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers), Liver Disease Diagnosis and Treatment (7 papers) and Diet and metabolism studies (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (314 citations), Cardiology and Cardiovascular Medicine (288 citations) and Surgery (475 citations). Daiana Ibarretxe has collaborated with scholars based in Spain, Italy and Norway. Frequent co-authors include L. Masana, Núria Plana, Josefa Girona, Mercedes Heras, Ricardo Rodríguez‐Calvo, Raimón Ferré, Cèlia Rodríguez-Borjabad, Núria Amigó, Alba Bosquet and Anna Cabré. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.